New Zealand markets close in 4 hours 50 minutes

PFE Sep 2024 42.500 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.2500-0.0600 (-19.35%)
As of 01:16PM EST. Market open.
Full screen
Previous close0.3100
Expiry date2024-09-20
Day's range0.2500 - 0.2500
Contract rangeN/A
Open interest929
  • Yahoo Finance

    AWS expands big pharma partnerships in manufacturing, AI, and R&D

    Pfizer and Amazon Web Services are just another example of how artificial intelligence is working in the background in healthcare.

  • GlobeNewswire

    Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at the 2023 San Antonio Breast Cancer Symposium

    -- Six abstracts have been accepted for presentation, including updated data on vepdegestrant alone and in combination with palbociclib (IBRANCE®) -- NEW HAVEN, Conn. and NEW YORK, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced that updated clinical trial data for vepdegestrant (ARV-471) will be presented at the 2023 San Antonio Breast Cancer Symposium (SABCS). Vepdegestrant is a novel oral PROteolysis TArgeting Chimera (PROTAC®) estrog

  • Insider Monkey

    12 Very High Yield Dividend Stocks With Upside Potential

    In this article, we discuss 12 very high yield dividend stocks with upside potential. You can skip our detailed analysis of dividend stocks and their performance in the past, and go directly to read 5 Very High Yield Dividend Stocks With Upside Potential. Many investors are drawn to dividend investing for various reasons, but among […]